ACLA News

Rep. Michael Burgess to Provide a View on Health Care From Capitol Hill at 2017 ACLA Annual Meeting

January 25, 2017 Categories: ACLA News, News, Featured News, ACLA Press Releases

(Washington, D.C.) – Adding to the list of esteemed health policy speakers presenting at the annual conference of the nation’s largest trade association representing clinical laboratories, the  American Clinical Laboratory Association (ACLA), announced today physician and Chair of the House Energy & Commerce Subcommittee on Health, Rep. Michael Burgess (R-TX), M.D., will address pressing health care issues during the first 100 days of the Trump Administration and the 115th Congress.

“One of the most important and influential voices in health care policy today, Chairman Burgess has demonstrated a keen understanding of issues facing the clinical laboratory community,” said Julie Khani, president of ACLA.  “ACLA members are looking forward to hearing from the chairman regarding policy impacting diagnostic innovation and its role in ongoing advances in patient care.”

ACLA’s annual meeting will be held March 23rd, 2017 at the Grand Hyatt Hotel in Washington, D.C.  Joining Burgess in addressing representatives from laboratories, government, patient and the payor community are Marc Boutin, CEO of the National Health Council who will be moderating a panel featuring patient advocacy organizations, Karen Glassman of the Health and Human Services (HHS) Office of the Inspector General (OIG) and keynote speaker Siddhartha Mukherjee, M.D., Assistant Professor of Medicine at Columbia University, the author of The Emperor of All Maladies:  A Biography of Cancer, and winner of the 2011 Pulitzer Prize for general nonfiction.

“ACLA’s annual meeting is scheduled at an opportune time that will allow for thoughtful perspectives from leaders in the legislative and regulatory policy arena and those on the cutting edge of medical science,” said Julie Khani, president of ACLA.  “Our meeting agenda represents the exciting intersection of health care policy and advances in innovation – both of which will lead the way in precision medicine and the quest for effective treatments and cures.”

ACLA’s annual conference is the premier meeting for the clinical lab community that brings together national leaders in the diagnostic sector, payors, patients, congressional lawmakers and administration officials for presentations and discussions on federal legislative and regulatory policy.

For more information, visit the ACLA annual meeting website, click here.

 

# # #

The ACLA is a not-for-profit association representing the nation’s leading national, regional and esoteric clinical laboratories on key issues of common concern, including federal and state government reimbursement and regulatory policies. 

 

Print Friendly, PDF & Email